EUVIMED · CrossrefZeitschrift
Fibrinolysis and Proteolysis
ISSN 1369-0191 · Elsevier BV
Neueste Artikel
Intraoperativelym-administered aprotinin and survival after elective liver resection for colorectal cancer metastasis A preliminary study
Editorial Board
Editorial
Cross-talk among proteases and matrix in the control of growth factor action
Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay
Low-dose infusion of recombinant tissue-type plasminogen activator in healthy volunteers to investigate the biodistribution of t-PA in the early phase of infusion
Binding of plasminogen and tissue-type plasminogen activator to dimeric αs2-casein accelerates plasmin generation
Expression, purification, and characterization of recombinant rat plasminogen activator inhibitor-1
A novel inhibitor of plasminogen activator inhibitor-1 production, T-686: direct effects on the fibrinolytic system
XR5118, a novel modulator of plasminogen activator inhibitor-1 (PAI-1), increases endogenous tPA activity in the rat
Hormonal regulation of the expression of fibrinolytic components in HT1080 fibrosarcoma and endothelial cells
Announcements
Foreword
Gene-environment interaction in the determination of plasma levels of fibrinogen
Experiments on the risk factor role of fibrinogen
How does hyperfibrinogenemia lead to thrombosis?
Fibrinogen and atherosclerosis: a study in transgenic mice
How to detect activated coagulation
Fibrinogen mediates vasoactive effects in saphenous vein by an ICAM-1 dependent pathway
Recent advances in hemostatic risk factors and cardiovascular diseases
Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
Variables of the fibrinolytic system: risk indicators for CHD
Hyperinsulinemia increases plasma activity of PAI-1 in vivo independently of an acute phase reaction
Endogenous fibrinolytic function and risks of future myocardial infarction and stroke: observations from the Physicians' Health Study
Molecular markers of hemostasis and fibrinolysis and inhibitor levels in unstable angina pectoris
Some interactions between the haemostatic system and lipids
Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease
Homocysteine, atherogenesis and thrombosis
Urinary 8-EPI PGF2α: an index of oxidant stress in vivo
EUVIMED